Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor

Background. Ivacaftor improves outcomes in cystic fibrosis (CF) patients with the G551D mutation; however, effects on respiratory microbiology are largely unknown. This study examines changes in CF respiratory pathogens with ivacaftor and correlates them with baseline characteristics and clinical re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Infect Dis
Hauptverfasser: Heltshe, Sonya L., Mayer-Hamblett, Nicole, Burns, Jane L., Khan, Umer, Baines, Arthur, Ramsey, Bonnie W., Rowe, Steven M.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Oxford University Press 2015
Schlagworte:
Articles and Commentaries
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4342673/
https://ncbi.nlm.nih.gov/pubmed/25425629
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciu944
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge